Related Experiment Video
Updated: May 28, 2026

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions
Published on: May 28, 2017
Exploiting the Notch pathway in HTLV-1-driven adult T-cell leukemia/lymphoma: a mini-review
Mohammad Mehdi Akbarin1,2, Zahra Farjami1,3, Hugo Ramírez Álvarez4
1Virology, Genetics, and Molecular Biology Laboratory, Faculty of Higher Studies Cuautitlán, Veterinary Medicine, Campus 4, National Autonomous University of Mexico, Cuautitlán-Teoloyucan Highway, Km. 2.5, San Sebastián Xhala, Cuautitlan Izcalli, 54714, Mexico.
Human T-cell leukemia virus type 1 (HTLV-1) hijacks Notch signaling, a critical pathway for T-cell function, to drive adult T-cell leukemia/lymphoma (ATLL) development. Targeting Notch shows promise but faces clinical challenges.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATLL) and inflammatory diseases.
- The precise molecular mechanisms of HTLV-1 pathogenesis are not fully understood.
- Notch signaling is crucial for T-cell biology, immune evasion, and leukemogenesis.
Purpose of the Study:
- To review the role of Notch signaling in HTLV-1 infection and ATLL pathogenesis.
- To discuss the therapeutic strategies targeting the Notch pathway in HTLV-1-associated malignancies.
Main Methods:
- Review of existing literature on HTLV-1, Notch signaling, and ATLL.
- Analysis of molecular mechanisms involving HTLV-1 proteins (Tax, HBZ) and Notch pathway components.
- Evaluation of preclinical and clinical data on Notch-targeted therapies.
Main Results:
- HTLV-1 proteins modulate Notch activity, leading to constitutive activation and oncogenic transformation.
- Mutations in NOTCH1 and FBXW7 stabilize Notch signaling, promoting proliferation and survival.
- JAG1 overexpression and crosstalk with PI3K/STAT3 pathways contribute to Notch-driven ATLL phenotypes.
- Preclinical inhibition of Notch reduces ATLL cell growth, but clinical efficacy is limited.
Conclusions:
- Notch signaling is a key player in HTLV-1-driven leukemogenesis.
- Targeting Notch offers therapeutic potential for ATLL, but challenges remain.
- Further understanding of Notch pathway intricacies is needed for effective interventions.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers

